Search
Close this search box.
Search
Subscriber Log In
Evaluate Consulting and Analytics

Data and Expertise – A Holistic Approach to Problem-Solving

Evaluate’s pharmaceutical consulting and analytics team is here to help clients address unique scientific, clinical and commercial challenges. We answer key asset, portfolio, and corporate strategy-related business questions​, powered by the combined resources of Norstella, one of the world’s largest pharma intelligence solutions providers.​

With a team of over 70 consultants globally, extensive data assets, and experience across therapy areas and modalities, we specialise in the areas of Portfolio Strategy, Licensing and Transaction Advisory and Competitive Intelligence.

Your unique commercial and clinical decisions require a partner who understands your business. Evaluate’s combination of leading data sources, deep pharma expertise, robust methodologies, data science and real-world data will ensure your teams make the right decisions to drive your growth.

Ready to learn more?
Contact us today to get started.

Our Capabilities

Asset & Portfolio Strategy

Competitive Intelligence

Business Development & Licensing

How can you objectively determine the true worth of acquisition and licensing targets and accurately assess the health of your portfolio? Our team can provide insights to enable informed portfolio strategy decisions. We can help you with tailored:

  • Market sizing and forecasting
  • Commercial opportunity assessment
  • Indication prioritisation and strategy
  • Portfolio optimisation

Competition in biopharma is fierce. Evaluate’s CI practice provides clinical and commercial teams with the support to understand their evolving competitive landscape and to facilitate strategic decision making. We help with:

  • Competitor and market insights
  • Competitor monitoring
  • Customised dashboards and analytics
  • Strategic workshops and recommendations

Our experts partner with clients to address business questions throughout the BD&L process. They streamline decision-making to build commercially-focused pipelines and help address the balance between internal and external innovation, offering;

  • In licensing candidate long list generation and prioritisation
  • Out licensing partner identification, prioritisation and outreach
  • Asset valuation and due diligence
  • Innovation trends analysis
  • Pipeline tracking and competitor monitoring

Our Capabilities

How can you objectively determine the true worth of acquisition and licensing targets and accurately assess the health of your portfolio? Our team can provide insights to enable informed portfolio strategy decisions. We can help you with tailored:

  • Market sizing and forecasting
  • Commercial opportunity assessment
  • Indication prioritisation and strategy
  • Portfolio optimisation

Competition in biopharma is fierce. Evaluate’s CI practice provides clinical and commercial teams with the support to understand their evolving competitive landscape and to facilitate strategic decision making. We help with:

  • Competitor and market insights
  • Competitor monitoring
  • Customised dashboards and analytics
  • Strategic workshops and recommendations

Dealmaking is the lifeblood of the biopharma market and the right partner or acquisition target is a game-changing for biotechs and pharma companies alike. Our experts have deep expertise in supporting successful transactions, offering;

  • Business development and licensing strategy and options analysis
  • Opportunity assessment and partner-finding
  • Buy/sell-side due diligence
  • Transaction planning and execution

Supporting Your Strategic Decision-Making.

Leveraging a foundation of extensive Evaluate data, augmented with secondary research, modelling and analysis, our pharmaceutical consulting solutions are data-driven and insight-focused. We also conduct targeted primary research with key opinion leaders, healthcare professionals and payers to validate our assumptions and test our hypotheses.

As part of Norstella, our team has access to an unparalleled range of insights, expertise and deep industry knowledge.

Evaluate makes it possible for us to assess the commercial value for different products, as well as understand the major trends in the pharmaceutical industry.

TOP 25 PHARMA COMPANY

Our Team